Trustmark Corp (TRMK) stock
TRMKNasdaqNational Commercial BanksFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/300% below fair value
$47.84+2.28 (+5.00%)
Close on Nov 12, 2026Market cap $2.78BP/E 12.0Yield 2.01%
Trustmark EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Trustmark's EPS for the twelve months ending Sep 30, 2026 was $4.00, up 9.3% year over year. For fiscal 2025 it was $3.70, up 1.9% from the year before. Over ten years it grew 8.0% a year on average. The highest annual figure on record is $3.70 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.70 | +1.9% |
| FY2024 | Dec 31, 2024 | $3.63 | +34.4% |
| FY2023 | Dec 31, 2023 | $2.70 | +130.8% |
| FY2022 | Dec 31, 2022 | $1.17 | -50.0% |
| FY2021 | Dec 31, 2021 | $2.34 | -6.8% |
| FY2020 | Dec 31, 2020 | $2.51 | +8.2% |
| FY2019 | Dec 31, 2019 | $2.32 | +5.0% |
| FY2018 | Dec 31, 2018 | $2.21 | +41.7% |
| FY2017 | Dec 31, 2017 | $1.56 | -2.5% |
| FY2016 | Dec 31, 2016 | $1.60 | -6.4% |
| FY2015 | Dec 31, 2015 | $1.71 | -6.6% |
| FY2014 | Dec 31, 2014 | $1.83 | +4.6% |
| FY2013 | Dec 31, 2013 | $1.75 | -3.3% |
| FY2012 | Dec 31, 2012 | $1.81 | +9.0% |
| FY2011 | Dec 31, 2011 | $1.66 | +5.7% |
| FY2010 | Dec 31, 2010 | $1.57 | +24.6% |
| FY2009 | Dec 31, 2009 | $1.26 | -20.8% |
| FY2008 | Dec 31, 2008 | $1.59 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.00 | +6.4% |
| Q2 FY2026 | Jun 30, 2026 | $1.08 | +17.4% |
| Q1 FY2026 | Mar 31, 2026 | $0.95 | +8.0% |
| Q4 FY2025 | Dec 31, 2025 | $0.97 | +5.4% |
| Q3 FY2025 | Sep 30, 2025 | $0.94 | +11.9% |
| Q2 FY2025 | Jun 30, 2025 | $0.92 | -23.3% |
| Q1 FY2025 | Mar 31, 2025 | $0.88 | +29.4% |
| Q4 FY2024 | Dec 31, 2024 | $0.92 | +55.9% |
| Q3 FY2024 | Sep 30, 2024 | $0.84 | +50.0% |
| Q2 FY2024 | Jun 30, 2024 | $1.20 | +62.2% |
| Q1 FY2024 | Mar 31, 2024 | $0.68 | -17.1% |
| Q4 FY2023 | Dec 31, 2023 | $0.59 | – |
| Q3 FY2023 | Sep 30, 2023 | $0.56 | -18.8% |
| Q2 FY2023 | Jun 30, 2023 | $0.74 | +32.1% |
| Q1 FY2023 | Mar 31, 2023 | $0.82 | +74.5% |
| Q4 FY2022 | Dec 31, 2022 | -$0.56 | -233.3% |
| Q3 FY2022 | Sep 30, 2022 | $0.69 | +102.9% |
| Q2 FY2022 | Jun 30, 2022 | $0.56 | -26.3% |
| Q1 FY2022 | Mar 31, 2022 | $0.47 | -42.7% |
| Q4 FY2021 | Dec 31, 2021 | $0.42 | -48.1% |
| Q3 FY2021 | Sep 30, 2021 | $0.34 | -60.5% |
| Q2 FY2021 | Jun 30, 2021 | $0.76 | +49.0% |
| Q1 FY2021 | Mar 31, 2021 | $0.82 | +134.3% |
| Q4 FY2020 | Dec 31, 2020 | $0.81 | +52.8% |
| Q3 FY2020 | Sep 30, 2020 | $0.86 | +34.4% |
| Q2 FY2020 | Jun 30, 2020 | $0.51 | -21.5% |
| Q1 FY2020 | Mar 31, 2020 | $0.35 | -31.4% |
| Q4 FY2019 | Dec 31, 2019 | $0.53 | -3.6% |
| Q3 FY2019 | Sep 30, 2019 | $0.64 | +18.5% |
| Q2 FY2019 | Jun 30, 2019 | $0.65 | +10.2% |
| Q1 FY2019 | Mar 31, 2019 | $0.51 | -5.6% |
| Q4 FY2018 | Dec 31, 2018 | $0.55 | +139.1% |
| Q3 FY2018 | Sep 30, 2018 | $0.54 | +5.9% |
| Q2 FY2018 | Jun 30, 2018 | $0.59 | +68.6% |
| Q1 FY2018 | Mar 31, 2018 | $0.54 | +17.4% |
| Q4 FY2017 | Dec 31, 2017 | $0.23 | -46.5% |
| Q3 FY2017 | Sep 30, 2017 | $0.51 | – |
| Q2 FY2017 | Jun 30, 2017 | $0.35 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.46 | – |
| Q4 FY2016 | Dec 31, 2016 | $0.43 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?